{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:37:48Z","timestamp":1787564268072,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jdermsci.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T13:49:19Z","timestamp":1556718559000},"page":"259-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?"],"prefix":"10.1016","volume":"94","author":[{"given":"Yoshihide","family":"Asano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Saigusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2019.04.007_bib0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0010","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0015","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","article-title":"The role of genetics and epigenetics in the pathogenesis of systemic sclerosis","volume":"10","author":"Broen","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0025","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/clim.1999.4694","article-title":"Gammadelta receptor bearing T cells in scleroderma: enhanced interaction with vascular endothelial cells in vitro","volume":"91","author":"Kahaleh","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0045","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatol. Oxford (Oxford)"},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-4-15","article-title":"Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide","volume":"4","author":"Tourkina","year":"2011","journal-title":"Fibrogenesis Tissue Rep."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134092","article-title":"Partially evoked epithelial-mesenchymal transition (EMT) is associated with increased TGF\u03b2 signaling within lesional scleroderma skin","volume":"10","author":"Nikitorowicz-Buniak","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0065","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0070","first-page":"1268","article-title":"Localization of endothelin-1 and its binding sites in scleroderma skin","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0075","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI117154","article-title":"Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta","volume":"93","author":"Rudnicka","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0080","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S","article-title":"Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis","volume":"44","author":"Distler","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2005.10.007","article-title":"The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis","volume":"37","author":"Davies","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0090","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.20883","article-title":"Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0095","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/rheumatology\/ken370","article-title":"Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer","volume":"47","author":"Aden","year":"2008","journal-title":"Rheumatol. Oxford (Oxford)"},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0100","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","article-title":"Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis","volume":"130","author":"Aden","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0105","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/jid.2014.253","article-title":"Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9","volume":"134","author":"Nikitorowicz-Buniak","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biocel.2015.06.004","article-title":"Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis","volume":"67","author":"Asano","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0115","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0120","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0125","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0135","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/annrheumdis-2015-207483","article-title":"Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis","volume":"75","author":"Romano","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0140","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0145","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.39062","article-title":"Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific fli-1-knockout mice by increasing fli-1 DNA binding ability","volume":"67","author":"Akamata","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjd.14183","article-title":"Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions","volume":"174","author":"Saigusa","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0155","article-title":"Cyclophosphamide pulse therapy normalizes vascular abnormalities in a mouse model of systemic sclerosis vasculopathy","author":"Yamashita","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0160","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/rheumatology\/kex280","article-title":"Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta","volume":"56","author":"McCoy","year":"2017","journal-title":"Rheumatology Oxford (Oxford)"},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0165","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1091\/mbc.e08-02-0166","article-title":"Galectin-7 in the control of epidermal homeostasis after injury","volume":"19","author":"Gendronneau","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0170","doi-asserted-by":"crossref","DOI":"10.1111\/exd.13900","article-title":"A potential contribution of decreased galectin-7 expression in stratified epithelia to the development of cutaneous and esophageal manifestations in systemic sclerosis","author":"Saigusa","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0175","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/1346-8138.14161","article-title":"Diagnostic criteria, severity classification and guidelines of localized scleroderma","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jdermsci.2017.12.005","article-title":"Systemic sclerosis complicated with localized scleroderma-like lesions induced by Kobner phenomenon","volume":"89","author":"Saigusa","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0185","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/jdv.12280","article-title":"Histological features of localized scleroderma\u2019 en coup de sabre\u2019: a study of 16 cases","volume":"28","author":"Taniguchi","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0190","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.4049\/jimmunol.171.9.4830","article-title":"IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells","volume":"171","author":"Kandere-Grzybowska","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.0022-202X.2004.22719.x","article-title":"S100 proteins in the epidermis","volume":"123","author":"Eckert","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0200","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/exd.13023","article-title":"S100A7 (psoriasin) inhibits human epidermal differentiation by enhanced IL-6 secretion through IkappaB\/NF-kappaB signalling","volume":"25","author":"Son","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000236334","article-title":"In situ localization of interleukin-6 in normal skin and atrophic cutaneous disease","volume":"99","author":"Romero","year":"1992","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0210","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1346-8138.13827","article-title":"Critical contribution of the interleukin-6\/signal transducer and activator of transcription 3 axis to vasculopathy associated with systemic sclerosis","volume":"44","author":"Taniguchi","year":"2017","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0215","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00404350","article-title":"Active proliferation of telangiectases in skin of patients with progressive systemic sclerosis (PSS)","volume":"279","author":"Kazandjian","year":"1986","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0225","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bjd.14718","article-title":"Psoriasin (S100A7) promotes stress-induced angiogenesis","volume":"175","author":"Vegfors","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000247216","article-title":"Pitting scars in progressive systemic sclerosis","volume":"187","author":"Maeda","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0235","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02505229","article-title":"Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases","volume":"288","author":"Algermissen","year":"1996","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0240","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0245","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bjd.14699","article-title":"A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis","volume":"175","author":"Takahashi","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.04.007_bib0250","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/phpp.12331","article-title":"Phototherapy in systemic sclerosis: review","volume":"33","author":"Chaowattanapanit","year":"2017","journal-title":"Photodermatol. Photoimmunol. Photomed."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181119301008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181119301008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:49:15Z","timestamp":1760330955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181119301008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0923181119301008"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2019.04.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}